Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $87.76 billion. The enterprise value is $109.67 billion.
Important Dates
The next estimated earnings date is Wednesday, July 16, 2025, before market open.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Jun 10, 2025 |
Share Statistics
Elevance Health has 225.93 million shares outstanding. The number of shares has decreased by -2.07% in one year.
| Current Share Class | 225.93M |
| Shares Outstanding | 225.93M |
| Shares Change (YoY) | -2.07% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 92.51% |
| Float | 225.42M |
Valuation Ratios
The trailing PE ratio is 15.17 and the forward PE ratio is 10.97. Elevance Health's PEG ratio is 1.25.
| PE Ratio | 15.17 |
| Forward PE | 10.97 |
| PS Ratio | 0.48 |
| Forward PS | 0.44 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 40.67 |
| P/FCF Ratio | 23.72 |
| P/OCF Ratio | 17.98 |
| PEG Ratio | 1.25 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.15, with an EV/FCF ratio of 29.85.
| EV / Earnings | 18.53 |
| EV / Sales | 0.60 |
| EV / EBITDA | 11.15 |
| EV / EBIT | 12.01 |
| EV / FCF | 29.85 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.43 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.99 |
| Debt / FCF | 8.17 |
| Interest Coverage | 7.23 |
Financial Efficiency
Return on equity (ROE) is 14.17% and return on invested capital (ROIC) is 8.17%.
| Return on Equity (ROE) | 14.17% |
| Return on Assets (ROA) | 4.93% |
| Return on Invested Capital (ROIC) | 8.17% |
| Return on Capital Employed (ROCE) | 11.86% |
| Revenue Per Employee | $1.76M |
| Profits Per Employee | $56,785 |
| Employee Count | 104,200 |
| Asset Turnover | 1.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.86 billion in taxes.
| Income Tax | 1.86B |
| Effective Tax Rate | 23.91% |
Stock Price Statistics
The stock price has decreased by -23.17% in the last 52 weeks. The beta is 0.67, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -23.17% |
| 50-Day Moving Average | 415.53 |
| 200-Day Moving Average | 433.07 |
| Relative Strength Index (RSI) | 45.01 |
| Average Volume (20 Days) | 1,707,286 |
Short Selling Information
The latest short interest is 2.61 million, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 2.61M |
| Short Previous Month | 3.06M |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.16% |
| Short Ratio (days to cover) | 1.55 |
Income Statement
In the last 12 months, Elevance Health had revenue of $183.12 billion and earned $5.92 billion in profits. Earnings per share was $25.60.
| Revenue | 183.12B |
| Gross Profit | 50.79B |
| Operating Income | 9.13B |
| Pretax Income | n/a |
| Net Income | 5.92B |
| EBITDA | 9.84B |
| EBIT | 9.13B |
| Earnings Per Share (EPS) | $25.60 |
Full Income StatementBalance Sheet
The company has $33.65 billion in cash and $30.00 billion in debt, giving a net cash position of -$22.50 billion or -$99.60 per share.
| Cash & Cash Equivalents | 33.65B |
| Total Debt | 30.00B |
| Net Cash | -22.50B |
| Net Cash Per Share | -$99.60 |
| Equity (Book Value) | 42.62B |
| Book Value Per Share | 188.37 |
| Working Capital | 18.42B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.85 billion and capital expenditures -$1.17 billion, giving a free cash flow of $3.67 billion.
| Operating Cash Flow | 4.85B |
| Capital Expenditures | -1.17B |
| Free Cash Flow | 3.67B |
| FCF Per Share | $16.26 |
Full Cash Flow StatementMargins
Gross margin is 27.74%, with operating and profit margins of 4.99% and 3.23%.
| Gross Margin | 27.74% |
| Operating Margin | 4.99% |
| Pretax Margin | 4.24% |
| Profit Margin | 3.23% |
| EBITDA Margin | 5.37% |
| EBIT Margin | 4.99% |
| FCF Margin | 2.01% |
Dividends & Yields
This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 1.76%.
| Dividend Per Share | $6.84 |
| Dividend Yield | 1.76% |
| Dividend Growth (YoY) | 7.40% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 26.71% |
| Buyback Yield | 2.07% |
| Shareholder Yield | 3.84% |
| Earnings Yield | 6.79% |
| FCF Yield | 4.21% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $519.76, which is 33.80% higher than the current price. The consensus rating is "Buy".
| Price Target | $519.76 |
| Price Target Difference | 33.80% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 18.12% |
Stock ForecastsStock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |